Jennerex Biotherapeutics
VerifiedClinical-stage biopharmaceutical company developing targeted oncolytic products for the treatment of cancer.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$7—11m (Dealroom.co estimates Oct 2011.)
San Francisco California (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | $0.0 | round | |
| N/A | $0.0 | round | |
| N/A | $0.0 | round | |
| N/A | $0.0 | round | |
| N/A | $0.0 | round | |
N/A | Acquisition | ||
| Total Funding | 000k | ||
Related Content
Recent News about Jennerex Biotherapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.